Comparison between Intravenous and Intranasal dexmedetomidine for changes in vitals during laryngoscopy and endotracheal intubation

Attenuation of Haemodynamic Responses to Laryngoscopy and endotracheal Intubation with Dexmedetomidine: A Comparison between Intravenous and Intranasal Route. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061781

Enrollment

100

Registered

2024-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K400- Bilateral inguinal hernia, with obstruction, without gangrene

Interventions

Intervention1: Intravenous dexmedetomidine: Intravenous dexmedetomidine for Laryngoscopy and endotracheal intubation , hemodynamic monitoring for 10 minutes Control Intervention1: Intranasal dexmedeto

Eligibility

Inclusion criteria

Inclusion criteria: Age18years-60years ASA grade1 and2 Scheduled for Laryngoscopy and endotracheal Intubation

Exclusion criteria

Exclusion criteria: Lack of patient’s consent. Age 60yrs. ASA grade 3 and more. Patients with hypersensitivity to any of the drugs used. Pregnant and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Hemodynamic stableTimepoint: 15 mins	—

Secondary

Measure	Time frame
Analgesic stabilityTimepoint: 15 mins	—

Countries

India

Contacts

Public ContactRohan Kanthed

Peoples medical college, bhopal

dr_sourabhjain@yahoo.com9826306570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026